Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131558) titled 'A Study of Short-Course Radiotherapy Followed by Subcutaneous Toripalimab Plus Capecitabine in Patients Aged 75 Years or Older With Locally Advanced Rectal Cancer' on Sept. 3.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking University Third Hospital
Condition:
pMMR/MSS Locally Advanced Rectal Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-03
Target Sample Size: Experimental Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341718
Disclaimer: Curated by HT Syndication....